Healthy volunteer study of inhaled CPD704
This early-phase study tests a new inhaled medication called CPD704 in healthy volunteers. It checks safety and how the body processes the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy person between 18 and 55 years old.
- Your weight is at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female.
- Your body mass index (BMI) is between 19 and 28.
- You do not have significant lung, heart, liver, kidney, or other chronic health problems.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study and will use birth control if needed.
- You are willing to not smoke, avoid alcohol and certain foods, and use a nebulizer correctly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
This is an early-stage safety study testing a new inhaled medication called RC010 in healthy volunteers. Researchers want to understand how safe it is, how well people tolerate it, and how the body processes it.
This trial tests a new inhaled drug, HSK39004, to see if it safely improves breathing and quality of life in people with moderate to severe COPD. You may join if you are between 40 and 80, have a COPD diagnosis with certain lung function results, and have at least some shortness of breath with daily activities.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.